Literature DB >> 10461748

The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.

B C Chia1, J A Carver, T D Mulhern, J H Bowie.   

Abstract

Uperin 3.6 (GVIDA5AKKVV10NVLKN15LF-NH2) is a wide-spectrum antibiotic peptide isolated from the Australian toadlet, Uperoleia mjobergii. With only 17 amino acid residues, it is smaller than most other wide-spectrum antibiotic peptides isolated from amphibians. In 50% (by vol.) trifluoroethanol, an NMR study and structure calculations indicate that uperin 3.6 adopts a well-defined amphipathic alpha-helix with distinct hydrophilic and hydrophobic faces. Examination of the activities of synthetic modifications of uperin 3.6 reveal that the three lysine residues are essential for antibiotic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461748     DOI: 10.1034/j.1399-3011.1999.00095.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  6 in total

Review 1.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.

Authors:  Andrea Giacometti; Oscar Cirioni; Wojciech Kamysz; Carmela Silvestri; Alberto Licci; Giuseppina D'Amato; Piotr Nadolski; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Population trends associated with skin peptide defenses against chytridiomycosis in Australian frogs.

Authors:  Douglas C Woodhams; Louise A Rollins-Smith; Cynthia Carey; Laura Reinert; Michael J Tyler; Ross A Alford
Journal:  Oecologia       Date:  2005-10-04       Impact factor: 3.225

4.  Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.

Authors:  Katarzyna Garbacz; Wojciech Kamysz; Lidia Piechowicz
Journal:  Virulence       Date:  2016-07-22       Impact factor: 5.882

5.  Activity of Novel Synthetic Peptides against Candida albicans.

Authors:  Kah Yean Lum; Sun Tee Tay; Cheng Foh Le; Vannajan Sanghiran Lee; Nadia Hanim Sabri; Rukumani Devi Velayuthan; Hamimah Hassan; Shamala Devi Sekaran
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

6.  In Vitro Efficiency of Antimicrobial Peptides against Staphylococcal Pathogens Associated with Canine Pyoderma.

Authors:  Małgorzata Jarosiewicz; Katarzyna Garbacz; Damian Neubauer; Wojciech Kamysz
Journal:  Animals (Basel)       Date:  2020-03-11       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.